Behavioral Weight Loss Treatment for Obesity
(REBOOT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores why individuals from disadvantaged backgrounds often face greater challenges in losing weight through behavioral programs. Researchers aim to understand how daily challenges and a focus on immediate rewards affect weight loss success. Participants will engage in a 6-month group-based weight loss program (behavioral weight loss treatment) designed by the CDC. Individuals with obesity from either lower or higher socioeconomic backgrounds may be suitable candidates, particularly if they are not currently involved in other weight loss treatments or planning to relocate soon. As an unphased trial, this study provides a unique opportunity to contribute to understanding weight loss challenges and potentially benefit from a tailored program.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are currently engaged in another weight loss therapy, you cannot participate.
What prior data suggests that this behavioral weight loss treatment is safe?
Research shows that behavioral weight loss programs are generally safe. These programs, which often involve changes in diet and exercise, are usually well-received by participants. For example, one study found that structured support and feedback enabled significant weight loss.
While specific side effects aren't mentioned in the sources, behavioral programs typically pose fewer risks than medications. They focus on lifestyle changes, reducing the chance of negative reactions. Additionally, these programs are widely used and have proven effective for weight loss over time.
In summary, current research supports the safety of behavioral weight loss programs. Participants usually find them manageable, with no major safety concerns reported.12345Why are researchers excited about this trial?
Researchers are excited about the behavioral weight loss treatment for obesity because it focuses on lifestyle changes using the CDC's Prevent T2 curriculum. Unlike other treatments that might involve medication or surgery, this approach emphasizes group-based support, which can enhance motivation and accountability. Additionally, the structured six-month program provides a comprehensive framework that encourages sustainable changes in diet and physical activity, potentially leading to long-term success in weight loss and improved health outcomes.
What evidence suggests that this behavioral weight loss treatment might be effective for obesity?
Research has shown that behavioral weight loss programs can effectively help people lose weight. These programs involve changes in diet and exercise, often leading to a loss of about 5% of body weight. A review of several studies found that programs lasting six months or less often result in successful weight loss. Many participants in various studies also lost a significant amount of weight over a year. This trial will evaluate a standard-of-care behavioral weight loss treatment, following the Centers for Disease Control and Prevention's Prevent T2 curriculum, to determine its effectiveness in managing obesity.34678
Are You a Good Fit for This Trial?
This trial is for adults over 18 with obesity (BMI ≥30 kg/m2) who fall into specific socioeconomic status (SES) groups. Participants must live within 20 miles of Rush and have phone access. Those with a BMI over 60, severe medical conditions, cognitive impairments, substance abuse issues, or not fluent in English cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 6 months of group-based behavioral weight loss treatment following the CDC Prevent T2 curriculum
Follow-up
Participants are monitored for weight change and adherence to weight control behaviors
What Are the Treatments Tested in This Trial?
Interventions
- Behavioral weight loss treatment
Behavioral weight loss treatment is already approved in United States, European Union for the following indications:
- Obesity
- Overweight
- Obesity
- Overweight
- Type 2 diabetes prevention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rush University Medical Center
Lead Sponsor